SILDENAFIL CITRATE
| Brand name | REVATIO |
|---|---|
| Active ingredient | SILDENAFIL CITRATE |
| Strength | EQ 10MG BASE/12.5ML (EQ 0.8MG BASE/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | November 2009 |
| Marketing status | RX |
| Code | Expires |
|---|---|
| M-287 | January 2026 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.